NCT03013283

Brief Summary

Home ventilation techniques consist mainly of two techniques, Continuous Positive Airway Pressure or CPAP and Non Invasive Ventilation or NIV. Whether for CPAP or NIV, pressures are delivered to the patient via an interface. The efficacy of CPAP and NIV is conditioned in part by the observance of the patients to the device. Because the comfort and degree of satisfaction of the patients to its interface is a key factor of the observance, side-effects and satisfaction of patients need to be continuously evaluated with available interfaces for CPAP and NIV treated patients. The purpose of the research is the evaluation of interface side-effects and the degree of satisfaction of home care patients treated for at least three months with CPAP or NIV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

January 6, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

February 7, 2017

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

January 27, 2021

Status Verified

April 1, 2019

Enrollment Period

2.1 years

First QC Date

December 23, 2016

Last Update Submit

January 24, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Interface side effects and degree of satisfaction of the patients

    During a scheduled home visit of the technician. The primary endpoint is a composite criterion corresponding to the patients' responses to a self-administered questionnaire.

    1 day

Secondary Outcomes (14)

  • Identification by the technician of the problems of pain

    1 day

  • Percentage of patients with oxygen therapy, heated humidifier, chinstrap.

    1 day

  • Collection by technician of the type of interface

    1 day

  • Compliance

    1 day

  • Average level of intentional or unintentional leakage

    1 day

  • +9 more secondary outcomes

Interventions

* Interface side effects and degree of satisfaction of the patients * Technician evaluation and device measures.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The patients included in the study corresponded to the annual cohort of patients cared by the APARD home care provider. Patients are were treated with CPAP or VIN for more than 3 months according to the criteria of care and reimbursement of the French Social Security rules.

You may qualify if:

  • Written informed consent
  • Age more than 18 years (inclusive)
  • Patient treated with CPAP or NIV for at least three months,and eligible for care and for the reimbursement by the French Social Security rules.
  • Patient presents during a scheduled home visit of the technician for the continuation of CPAP or NIV treatment according to the French Social Security rules.

You may not qualify if:

  • Pregnancy, intention of being pregnant, breastfeeding.
  • Inability to understand the nature and aims of the study or to communicate with the investigator
  • No affiliation to the French social security
  • Loss of personal capacity resulting in state protection
  • Deprivation of liberty by judicial or administrative decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire de Montpellier

Montpellier, 34295, France

Location

CHU Saint-Etienne

Saint-Etienne, 42055, France

Location

Related Publications (5)

  • Rotty MC, Mallet JP, Suehs CM, Martinez C, Borel JC, Rabec C, Bourdin A, Molinari N, Jaffuel D. Is the 2013 American Thoracic Society CPAP-tracking system algorithm useful for managing non-adherence in long-term CPAP-treated patients? Respir Res. 2019 Sep 12;20(1):209. doi: 10.1186/s12931-019-1150-7.

  • Rotty MC, Suehs CM, Mallet JP, Martinez C, Borel JC, Rabec C, Bertelli F, Bourdin A, Molinari N, Jaffuel D. Mask side-effects in long-term CPAP-patients impact adherence and sleepiness: the InterfaceVent real-life study. Respir Res. 2021 Jan 15;22(1):17. doi: 10.1186/s12931-021-01618-x.

  • Vidal C, Mallet JP, Skinner S, Gilson R, Gaubert O, Prigent A, Gagnadoux F, Borel JC, Bourdin A, Molinari N, Jaffuel D. Positive Airway Pressure-Related Aerophagia in Obstructive Sleep Apnea: Results from the InterfaceVent Real-Life Study. J Clin Med. 2025 Sep 11;14(18):6424. doi: 10.3390/jcm14186424.

  • Vidal C, Bertelli F, Mallet JP, Gilson R, Borel JC, Gagnadoux F, Skinner S, Bourdin A, Molinari N, Jaffuel D. Added value of technician intervention to improve mask management for apneic patients treated with long-term CPAP. Sleep Breath. 2025 Feb 28;29(1):117. doi: 10.1007/s11325-025-03279-2.

  • Vidal C, Bertelli F, Mallet JP, Gilson R, Borel JC, Gagnadoux F, Bourdin A, Molinari N, Jaffuel D. Mask side-effects are related to gender in long-term CPAP: results from the InterfaceVent real-life study. Respir Res. 2024 Sep 6;25(1):331. doi: 10.1186/s12931-024-02965-1.

Related Links

MeSH Terms

Conditions

Sleep Apnea SyndromesSleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Dany JAFFUEL, MD, PhD

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2016

First Posted

January 6, 2017

Study Start

February 7, 2017

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

January 27, 2021

Record last verified: 2019-04

Locations